The Feasibility, Acceptability, and Effectiveness of Electronic Patient-Reported Outcome Symptom Monitoring for Immune Checkpoint Inhibitor Toxicities: A Systematic Review.

Julia Lai-Kwon Jordan E CohenKarolina LisyClaudia RutherfordAfaf Girgis Ethan M Basch Michael Jefford

Published in: JCO clinical cancer informatics (2023)

There is preliminary evidence of the feasibility and acceptability of ePRO symptom monitoring for irAEs. However, further studies are needed to confirm the impact on ICI-specific outcomes, such as the frequency of grade 3-4 irAEs and duration of immunosuppression. Suggestions for the content and features of future ePRO systems for irAEs are provided.

Keyphrases

patient reported outcomes
randomized controlled trial
systematic review
patient reported
current status
type diabetes
case control
skeletal muscle
insulin resistance